New

Johnson & Johnson

The AI engine Fit Assessment

Beta

Johnson & Johnson is a leading healthcare company that develops and sells a wide range of medical devices and pharmaceuticals. Their focus includes innovative solutions aimed at addressing various health challenges across multiple therapeutic areas.

Blurb

Johnson & Johnson develops medical devices, pharmaceuticals, and consumer packaged goods.

HQ Location

New Brunswick (United States)

Founded

1886

Employees

+10000

Total funding raised

Not available

Last Funding Event

IPO, September 24, 1944

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Mobile Health Applications

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.